HEI3090

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

HEI3090 is a P2X7R activator. HEI3090 stimulates dendritic cells expressing P2X7R to produce IL-18, which subsequently promotes Natural Killer cells and CD4 T cells within tumors to produce IFN-γ, leading to a sustained antitumor response. HEI3090 can be used to enhance the efficacy of αPD-1 therapy in non-small cell lung cancer (NSCLC).

For research use only. We do not sell to patients.

  • Purity: 99.00%
  • CAS No.: 2377167-56-9
  • Formula: C18H15Cl3N4O3
  • Molecular Weight:441.70
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) HEI3090

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00